Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xueheng Cheng

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Biomolecular Screening|September 16, 2006
An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurFKenneth M Comess, Mark E Schurdak, Martin J Voorbach, et al.
Journal of Biomolecular Screening|September 8, 2006
Kinase drug discovery by affinity selection/mass spectrometry (ASMS): application to DNA damage checkpoint kinase Chk1Kenneth M Comess, Jonathan D Trumbull, Chang Park, et al.
ACS Chemical Biology|November 25, 2010
Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinasesKenneth M Comess, Chaohong Sun, Cele Abad-Zapatero, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Biomolecular Screening|September 16, 2006
An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurFKenneth M Comess, Mark E Schurdak, Martin J Voorbach, et al.
Journal of Biomolecular Screening|September 8, 2006
Kinase drug discovery by affinity selection/mass spectrometry (ASMS): application to DNA damage checkpoint kinase Chk1Kenneth M Comess, Jonathan D Trumbull, Chang Park, et al.
ACS Chemical Biology|November 25, 2010
Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinasesKenneth M Comess, Chaohong Sun, Cele Abad-Zapatero, et al.
Pageof 2